THERAPEUTIC EFFECT OF LISURIDE IN ADVANCED PARKINSONS-DISEASE

被引:5
|
作者
MENEGHETTI, G
BRACCO, F
GIOMETTO, B
FERLA, S
SCHERGNA, E
机构
关键词
D O I
10.1159/000115990
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:74 / 80
页数:7
相关论文
共 50 条
  • [1] LISURIDE INFUSION THERAPY IN ADVANCED PARKINSONS-DISEASE
    HASSAN, MN
    GRIMES, JD
    ROBERTS, J
    THAKAR, JH
    PAYNE, L
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 13 (02) : 172 - 173
  • [2] LISURIDE IN PARKINSONS-DISEASE
    LEIGUARDA, R
    MICHELI, F
    PARDAL, MF
    MEDICINA-BUENOS AIRES, 1985, 45 (01) : 29 - 34
  • [3] LISURIDE IN PARKINSONS-DISEASE
    LIEBERMAN, AN
    NEOPHYTIDES, A
    LEIBOWITZ, M
    KUPERSMITH, M
    WALKER, R
    ZASORIN, N
    KLEINBERG, D
    GOLDSTEIN, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (02) : 266 - 267
  • [4] LISURIDE IN PARKINSONS-DISEASE
    SCHACHTER, M
    BLACKSTOCK, J
    DICK, JPR
    GEORGE, RJD
    MARSDEN, CD
    PARKES, JD
    LANCET, 1979, 2 (8152): : 1129 - 1129
  • [5] COMPARISON OF LISURIDE AND BROMOCRIPTINE IN THE TREATMENT OF ADVANCED PARKINSONS-DISEASE
    LAIHINEN, A
    RINNE, UK
    SUCHY, I
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (06): : 593 - 595
  • [6] LISURIDE INFUSION FOR PARKINSONS-DISEASE
    OBESO, JA
    LUQUIN, MR
    LAGE, JMM
    ANNALS OF NEUROLOGY, 1983, 14 (01) : 134 - 134
  • [7] ORAL LISURIDE FOR PARKINSONS-DISEASE
    OBESO, JA
    LUQUIN, MR
    LAGE, JMM
    MEDICINA CLINICA, 1985, 85 (08): : 307 - 312
  • [8] PERGOLIDE AND LISURIDE FOR PARKINSONS-DISEASE
    LIEBERMAN, AN
    LEIBOWITZ, M
    NEOPHYTIDES, A
    KUPERSMITH, M
    MEHL, S
    KLEINBERG, D
    SERBY, M
    GOLDSTEIN, M
    LANCET, 1979, 2 (8152): : 1129 - 1130
  • [9] COMPARISON BETWEEN THERAPEUTIC ACTIVITY OF LISURIDE AND BROMOCRIPTINE IN PARKINSONS-DISEASE
    AGNOLI, A
    RUGGIERI, S
    BALDASSARRE, M
    DELROSCIO, S
    STOCCHI, F
    MARTUCCI, N
    PHARMACOLOGY, 1982, 24 (02) : 134 - 135
  • [10] DISPOSITION OF ORAL LISURIDE IN PARKINSONS-DISEASE
    BURNS, RS
    GOPINATHAN, G
    HUMPEL, M
    DOROW, R
    CALNE, DB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (04) : 548 - 556